A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy Volunteers

In brief

The purpose of this study is to evaluate the effect of BMS-986278 on the cardiac repolarization in healthy participants.

Key facts

Study ID

NCT07422298

Run by

Bristol-Myers Squibb

People needed

32

Starts

2026-02-19

Expected to finish

2026-06-14

Last updated by the study team

2026-08-03

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Female individuals not of childbearing potential and males.
• Healthy as determined by medical history, physical examination, vital signs, 12-lead ECG, and clinical laboratory assessments.
• 18 to 55 years of age, inclusive, at the time of signing the informed consent with a BMI 18.0 to 32.0 kg/m2, inclusive.
• Other protocol-defined Inclusion/Exclusion criteria apply.

Where it is running

• Local Institution - 0001 — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.